| abstract |
The present invention relates to a novel zygote sporox protein (EtOs22) belonging to a parasite of the species Eimeria tenella, a polynucleotide encoding this protein, a vector containing this polynucleotide, a cell transformed with these vectors, An antibody against a protein, the polynucleotide, the protein or a fragment thereof, the above vector or a vaccine containing the antibody against the protein, a polynucleotide or a polypeptide for finding an active compound for treating infection by Eimeria, and It relates to the use of active compounds, which are suitable for the treatment of Eimeria infections. |